The silent treatment: RNAi as a defense against virus infection in mammals.
about
Small Interfering RNA Pathway Modulates Initial Viral Infection in Midgut Epithelium of Insect after Ingestion of VirusRegulation of microRNA biogenesis and turnover by animals and their virusesTargeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine ProductionThe RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogasterExosomes derived from HIV-1-infected cells contain trans-activation response element RNACricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila.Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.Reduction in deformed wing virus infection in larval and adult honey bees (Apis mellifera L.) by double-stranded RNA ingestion.Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue virusesIn defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway.Sequence recombination and conservation of Varroa destructor virus-1 and deformed wing virus in field collected honey bees (Apis mellifera)The Baculovirus Antiapoptotic p35 Protein Functions as an Inhibitor of the Host RNA Interference Antiviral Response.Requirement for CRIF1 in RNA interference and Dicer-2 stability.Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.The Caenorhabditis elegans rsd-2 and rsd-6 genes are required for chromosome functions during exposure to unfavorable environmentsRNAi: antiviral therapy against dengue virusVirus meets RNAi. Symposium on antiviral applications of RNA interference.New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.CRISPRTarget: bioinformatic prediction and analysis of crRNA targets.The 5'-end heterogeneity of adenovirus virus-associated RNAI contributes to the asymmetric guide strand incorporation into the RNA-induced silencing complex.Engineering RNA for targeted siRNA delivery and medical application.High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells.The Functional Cycle of Rnt1p: Five Consecutive Steps of Double-Stranded RNA Processing by a Eukaryotic RNase III.Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA polymerase.Analysis of Acquisition and Titer of Maize Mosaic Rhabdovirus in Its Vector, Peregrinus maidis (Hemiptera: Delphacidae).Inhibition of porcine transmissible gastroenteritis virus infection in porcine kidney cells using short hairpin RNAs targeting the membrane gene.Distinct fitness costs associated with the knockdown of RNAi pathway genes in western corn rootworm adults.Short versus long double-stranded RNA activation of a post-transcriptional gene knockdown pathway.
P2860
Q26314662-9E99DA69-0159-4156-B2C3-B3386D80946FQ27014955-D0432934-67D2-4604-8CAF-427937B29CCDQ27490919-3574D6AF-54BB-4203-916F-4CB9C04B58F0Q28271770-C8824D46-0C15-4DAC-A706-6244F21BAEE4Q28290390-0BE257B9-CBB2-4D82-A8A3-FF994D01FBE4Q30556603-31FB6486-EBFB-4546-8DE8-EF014BB1622BQ33719287-64886361-262A-4683-ACF9-37970EDF1BB4Q34032356-3E0B2F26-C04D-42B8-BE11-EA04F7F98EA8Q34359759-93FBAD32-EDDC-40BA-9F13-B2EB4009D968Q34580667-4FE5BD07-4311-463D-B9FB-5D27AACF4643Q34742885-C209C1A1-6739-44D9-B36B-5060A4DEC63FQ34994735-455A13F9-A5F5-4DEA-8293-ED877BD927C2Q35914332-AA6333F3-DB35-460B-9537-37595AA1E70FQ36189985-E880FC13-7986-408D-AEB2-C1BCE6F7797BQ36304385-233C0EA8-28A5-4F50-B890-E10F88344C63Q36571718-E6A73CE0-8586-4ED0-A36B-F2E50EB3E200Q36782399-66DDE0DC-AC0C-4F2D-A02F-FC3271D6D996Q36835313-EA5D2846-B8A9-4565-8ED7-EE22B24861D6Q37001439-2D50BC5B-94BC-47FF-AD49-F85D409FCE81Q37019252-5A52DDD0-1D60-4439-8351-A309CEBEFCA8Q37079810-087295B0-853D-4957-B986-327E116282C3Q37421086-29EAE8D5-BC5F-4089-96EB-991A43B88415Q37709610-1339E17C-320B-4784-9AC5-D0125FD4ECABQ38651811-DF8FEF2D-9EA8-43AB-A92D-DF39BD49C617Q38857990-F4A82226-49AD-4319-BEB7-28AC0B38849BQ39006841-C14D4517-BDED-4BDC-BE79-8EACC8BE50D4Q40181185-4D09B065-38C8-47AA-840B-B38337AFA41FQ40376678-1F5D9680-90D8-4282-B250-6FA090B962C0Q40450230-220B8A72-65BD-45A5-ABB8-29731399297CQ47265155-6A46012C-BA6E-46B1-AEDC-4D19F4F51F27Q52541942-B7F9955F-B605-459E-A7CB-0C92032F952A
P2860
The silent treatment: RNAi as a defense against virus infection in mammals.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The silent treatment: RNAi as a defense against virus infection in mammals.
@ast
The silent treatment: RNAi as a defense against virus infection in mammals.
@en
type
label
The silent treatment: RNAi as a defense against virus infection in mammals.
@ast
The silent treatment: RNAi as a defense against virus infection in mammals.
@en
prefLabel
The silent treatment: RNAi as a defense against virus infection in mammals.
@ast
The silent treatment: RNAi as a defense against virus infection in mammals.
@en
P1476
The silent treatment: RNAi as a defense against virus infection in mammals.
@en
P2093
Raul Andino
Ronald P van Rij
P304
P356
10.1016/J.TIBTECH.2006.02.006
P577
2006-02-28T00:00:00Z